Rekha Kumar is an Endocrinology/Metabolic physician affiliated with Cornell University. OpenAlex indexes 55 publications with 2,006 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1165 York Avenue
Ground Floor
New York, NY 10065
Telephone
646-962-2111Registry record last updated 1 Aug 2019.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20255 payments
- Mannkind CorporationProgram year20251 payment
- Currax Pharmaceuticals LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
59.2%GLP-1 receptor agonist40.6%Mounjaro67%Ozempic27%Wegovy6%Part D<11 patientsBiguanide (metformin)18.6%Metformin Hcl Er82%Metformin Hcl18%Part D<11 patientsHormonal (systemic)
16.1%l-Thyroxine10.6%Synthroid51%Levothyroxine Sodium49%Part D≥16 patientsl-Triiodothyronine2.1%Liothyronine Sodium100%Part D<11 patients+ 2 more classes in this area
Nervous system
13.3%Other antiepileptics4.9%Topiramate100%Part D<11 patientsAminoketone4.3%Bupropion Xl65%Bupropion Hcl Sr36%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Attitudinal factors influencing willingness to use anti-obesity medication in adults with obesity
Current Research in Behavioral Sciences
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Devereux, MD
Cornell University
Thomas Walsh, MD
Cornell University
Cora Sternberg, MD
Cornell University
George Alexopoulos, MD
Cornell University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”